Toll-like receptor 4 in CNS pathologies

Journal of Neurochemistry

Volumn 114, Issue 1, 2010, Pages 13-27

  Buchanan, Madison M ^a   Hutchinson, Mark ^b   Watkins, Linda R ^a   Yin, Hang ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Endogenous ligand; Glia; MD 2; Neuroinflammation; Sepsis; Toll like receptor

Indexed keywords

6 [N (2 CHLORO 4 FLUOROPHENYL)SULFAMOYL] 1 CYCLOHEXENE 1 CARBOXYLIC ACID ETHYL ESTER; ERITORAN; MYELOID DIFFERENTIATION FACTOR 88; NALOXONE; NALTREXONE; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; DRUG PROTEIN BINDING; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SEPSIS;

ALZHEIMER DISEASE; ANIMALS; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; NEOPLASMS; NEUROGLIA; NEUROIMMUNOMODULATION; PAIN; SEPSIS; SIGNAL TRANSDUCTION; STROKE; SYNAPTIC TRANSMISSION; TOLL-LIKE RECEPTOR 4;

EID: 77953316285     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06736.x     Document Type: Review

References (118)

1. Aarum J., Sandberg K., Haeberlein S. L. Persson M. A. (2003) Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl Acad. Sci. USA, 100, 15983 15988.
2. Abate W., Alghaithy A. A., Parton J., Jones K. P. Jackson S. K. (2009) Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J. Lipid Res. 51, 334 344.
3. Akira S., Uematsu S. Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124, 783 801.
4. Akiyama H., Arai T., Kondo H., Tanno E., Haga C. Ikeda K. (2000) Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 14 (Suppl. 1 S47 S53.
5. Anderson K. V., Bokla L. Nusslein-Volhard C. (1985a) Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42, 791 798. (Pubitemid 16083720)
6. Anderson K. V., Jurgens G. Nusslein-Volhard C. (1985b) Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42, 779 789. (Pubitemid 16083719)
7. Arbour N. C., Lorenz E., Schutte B. C., Zabner J., Kline J. N., Jones M., Frees K., Watt J. L. Schwartz D. A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187 191.
8. Balistreri C. R., Candore G., Listi F., Fazio T., Gangi S., Incalcaterra E., Caruso M., Vecchi M. L., Lio D. Caruso C. (2007) Role of TLR4 polymorphisms in inflammatory responses: implications for unsuccessful aging. Ann. N. Y. Acad. Sci. 1119, 203 207.
9. Balistreri C. R., Colonna-Romano G., Lio D., Candore G. Caruso C. (2009) TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J. Clin. Immunol. 29, 406 415.
10. Blanco A. M., Valles S. L., Pascual M. Guerri C. (2005) Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J. Immunol. 175, 6893 6899.
11. Block M. L., Zecca L. Hong J. S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57 69.
12. Blanco A. M., Perez-Arago A., Fernandez-Lizarbe S. Guerri C. (2008) Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J. Neurochem. 106, 625 639.
13. Bowie A. O'Neill L. A. (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67, 508 514.
14. Cao C. X., Yang Q. W., Lv F. L., Cui J., Fu H. B. Wang J. Z. (2007) Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353, 509 514.
15. Caso J. R., Pradillo J. M., Hurtado O., Leza J. C., Moro M. A. Lizasoain I. (2008) Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 39, 1314 1320.
16. Cao L., Palmer C. D., Malon J. T. De Leo J. A. (2009) Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain. Eur. J. Immunol. 39, 3562 3569.
17. Caso J. R., Pradillo J. M., Hurtado O., Lorenzo P., Moro M. A. Lizasoain I. (2007) Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115, 1599 1608.
18. Chakravarty S. Herkenham M. (2005) Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 25, 1788 1796.
19. DeLeo J. A., Rutkowski M. D., Stalder A. K. Campbell I. L. (2000) Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport 11, 599 602.
20. Department of Health and Human Services, N. I. o. H. (1998) New directions in pain research S., Pascual M., Gascon M. S., Blanco A. Guerri C. (2008) Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Mol. Immunol. 45, 2007 2016.
21. Gangloff M., Weber A. N., Gibbard R. J. Gay N. J. (2003) Evolutionary relationships, but functional differences, between the Drosophila and human Toll-like receptor families. Biochem. Soc. Trans. 31, 659 663.
22. Glezer I., Lapointe A. Rivest S. (2006) Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20, 750 752.
23. Gradisar H., Keber M. M., Pristovsek P. Jerala R. (2007) MD-2 as the target of curcumin in the inhibition of response to LPS. J. Leukoc. Biol. 82, 968 974.
24. Hacker H., Redecke V., Blagoev B., et al. (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204 207.
25. Hashimoto C., Hudson K. L. Anderson K. V. (1988) The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52, 269 279.
26. Hickey E. J., You X., Kaimaktchiev V., Stenzel-Poore M. Ungerleider R. M. (2007) Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 133, 1588 1596.
27. Horng T., Barton G. M., Flavell R. A. Medzhitov R. (2002) The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329 333.
28. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K. Akira S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749 3752.
29. Hua F., Ma J., Ha T., et al. (2007) Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190, 101 111.
30. Hutchinson M. R., Bland S. T., Johnson K. W., Rice K. C., Maier S. F. Watkins L. R. (2007) Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal 7, 98 111.
31. Hutchinson M. R., Zhang Y., Brown K., et al. (2008) Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28, 20 29.
32. Hutchinson M. R., Ramos K. M., Loram L. C., et al. (2009a) Evidence for a role of heat shock protein-90 (HSP90) in TLR4 mediated pain enhancement in rats. Neuroscience. 164, 1821 1832.
33. Hutchinson M. R., Zhang Y., Shridhar M., et al. (2009b) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 24, 83 95.
34. Ii M., Matsunaga N., Hazeki K., Nakamura K., Takashima K., Seya T., Hazeki O., Kitazaki T. Iizawa Y. (2006) A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 69, 1288 1295.
35. Jou I., Lee J. H., Park S. Y., Yoon H. J., Joe E. H. Park E. J. (2006) Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am. J. Pathol. 168, 1619 1630.
36. Juni A., Klein G., Pintar J. E. Kest B. (2007) Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 147, 439 444.
37. Kagan J. C. Medzhitov R. (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943 955.
38. Kagan J. C., Su T., Horng T., Chow A., Akira S. Medzhitov R. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361 368.
39. Kakimura J., Kitamura Y., Takata K., et al. (2002) Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 16, 601 603.
40. Kawai T. Akira S. (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13, 460 469.
41. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G. Mattson M. P. (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69, 273 284.
42. Keller J. N., Hanni K. B. Markesbery W. R. (1999) 4-Hydroxynonenal increases neuronal susceptibility to oxidative stress. J. Neurosci. Res. 58, 823 830.
43. Kim H. M., Park B. S., Kim J. I., et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130, 906 917.
44. Kobayashi M., Saitoh S., Tanimura N., Takahashi K., Kawasaki K., Nishijima M., Fujimoto Y., Fukase K., Akashi-Takamura S. Miyake K. (2006) Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176, 6211 6218.
45. Konat G. W., Krasowska-Zoladek A. Kraszpulski M. (2008) Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation. J. Neurosci. Res. 86, 603 609.
46. Lawson L. J., Perry V. H., Dri P. Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151 170.
47. Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J. Vartanian T. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl Acad. Sci. USA 100, 8514 8519.
48. Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., Nitsch R. Weber J. R. (2008) A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28, 2320 2331.
49. Liu B., Du L., Kong L. Y., Hudson P. M., Wilson B. C., Chang R. C., Abel H. H. Hong J. S. (2000) Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97, 749 756.
50. Liu H., Xin L., Chan B. P., Teoh R., Tang B. L. Tan Y. H. (2002a) Interferon-beta administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia. Neurosci. Lett. 327, 146 148.
51. Liu Y., Qin L., Wilson B. C., An L., Hong J. S. Liu B. (2002b) Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302, 1212 1219.
52. Maier S. F., Wiertelak E. P., Martin D. Watkins L. R. (1993) Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res., 623, 321 324.
53. Maier S. F. Watkins L. R. (2003) Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain Behav. Immun. 17 (Suppl 1 S125 S131.
54. Marin-Teva J. L., Dusart I., Colin C., Gervais A., van Rooijen N. Mallat M. (2004) Microglia promote the death of developing Purkinje cells. Neuron 41, 535 547.
55. Marsh B., Stevens S. L., Packard A. E., Gopalan B., Hunter B., Leung P. Y., Harrington C. A. Stenzel-Poore M. P. (2009) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 9839 9849.
56. Marta M., Meier U. C. Lobell A. (2009) Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun. Rev. 8, 506 509.
57. Marx J. (2004a) Cancer research. Inflammation and cancer: the link grows stronger. Science 306, 966 968.
58. Marx J. (2004b) Pain research. Why other people may not feel your pain. Science 305, 328.
59. Mason P. (1993) Lipopolysaccharide induces fever and decreases tail flick latency in awake rats. Neurosci. Lett. 154, 134 136.
60. Medzhitov R., Preston-Hurlburt P. Janeway Jr. C. A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394 397.
61. Midwood K., Sacre S., Piccinini A. M., et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat. Med. 15, 774 780.
62. Milligan E. D. Watkins L. R. (2009) Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10, 23 26.
63. Minoretti P., Gazzaruso C., Vito C. D., Emanuele E., Bianchi M., Coen E., Reino M. Geroldi D. (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci. Lett. 391, 147 149.
64. Miyake K., Yamashita Y., Ogata M., Sudo T. Kimoto M. (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333 3340.
65. Nagai Y., Akashi S., Nagafuku M., et al. (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3, 667 672.
66. Nobel Lectures (1965) Physiology or Medicine 1922-1941: Nobel Lectures, Including Presentation Speeches And Laureates' Biographies. Elsevier Publishing Company
67. Ohnishi H., Tochio H., Kato Z., Orii K. E., Li A., Kimura T., Hiroaki H., Kondo N. Shirakawa M. (2009) Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc. Natl Acad. Sci. USA 106, 10260 10265.
68. Ohto U., Fukase K., Miyake K. Satow Y. (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316, 1632 1634.
69. Okamura Y., Watari M., Jerud E. S., Young D. W., Ishizaka S. T., Rose J., Chow J. C. Strauss III. J. F. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229 10233.
70. Pais T. F., Figueiredo C., Peixoto R., Braz M. H. Chatterjee S. (2008) Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflamm. 5, 43.
71. Park B. S., Song D. H., Kim H. M., Choi B. S., Lee H. Lee J. O. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191 1195.
72. Poikonen K., Lajunen T., Silvennoinen-Kassinen S., Leinonen M. Saikku P. (2009) Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro. Scand. J. Immunol. 70, 34 39.
73. Poltorak A., He X., Smirnova I., et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085 2088.
74. Prohinar P., Re F., Widstrom R., Zhang D., Teghanemt A., Weiss J. P. Gioannini T. L. (2007) Specific high affinity interactions of monomeric endotoxin.protein complexes with Toll-like receptor 4 ectodomain. J. Biol. Chem. 282, 1010 1017.
75. Rietschel E. T., Kirikae T., Schade F. U., et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217 225.
76. Rittirsch D., Flierl M. A., Day D. E., et al. (2009) Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways. PLoS Pathog. 5, e1000464.
77. Rosenzweig H. L., Lessov N. S., Henshall D. C., Minami M., Simon R. P. Stenzel-Poore M. P. (2004) Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35, 2576 2581.
78. Rossignol D. P., Wasan K. M., Choo E., Yau E., Wong N., Rose J., Moran J. Lynn M. (2004) Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers. Antimicrob. Agents Chemother. 48, 3233 3240.
79. Rowe D. C., McGettrick A. F., Latz E., et al. (2006) The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl Acad. Sci. USA 103, 6299 6304.
80. Sarnico I., Lanzillotta A., Benarese M., Alghisi M., Baiguera C., Battistin L., Spano P. Pizzi M. (2009) NF-kappaB dimers in the regulation of neuronal survival. Int. Rev. Neurobiol. 85, 351 362.
81. Schaefer L., Babelova A., Kiss E., et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 2223 2233.
82. Sha T., Sunamoto M., Kitazaki T., Sato J., Ii M. Iizawa Y. (2007) Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur. J. Pharmacol. 571, 231 239.
83. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K. Kimoto M. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777 1782.
84. Slivka P. F., Shridhar M., Lee G. I., et al. (2009) A peptide antagonist of the TLR4-MD2 interaction. Chembiochem 10, 645 649.
85. Smiley S. T., King J. A. Hancock W. W. (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167, 2887 2894.
86. Stewart W. F., Kawas C., Corrada M. Metter E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626 632.
87. Szabo G., Dolganiuc A., Dai Q. Pruett S. B. (2007) TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects. J. Immunol. 178, 1243 1249.
88. Tahara K., Kim H. D., Jin J. J., Maxwell J. A., Li L. Fukuchi K. (2006) Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129, 3006 3019.
89. Takashima K., Matsunaga N., Yoshimatsu M., Hazeki K., Kaisho T., Uekata M., Hazeki O., Akira S., Iizawa Y. Ii M. (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 1250 1262.
90. Tan L., Schedl P., Song H. J., Garza D. Konsolaki M. (2008) The Toll - >NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila. PLoS One 3, e3966.
91. Tang S. C., Arumugam T. V., Xu X., et al. (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl Acad. Sci. USA 104, 13798 13803.
92. Tang S. C., Lathia J. D., Selvaraj P. K., Jo D. G., Mughal M. R., Cheng A., Siler D. A., Markesbery W. R., Arumugam T. V. Mattson M. P. (2008) Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 213, 114 121.
93. Tanga F. Y., Nutile-McMenemy N. DeLeo J. A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl Acad. Sci. USA 102, 5856 5861.
94. Tanimura N., Saitoh S., Matsumoto F., Akashi-Takamura S. Miyake K. (2008) Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 368, 94 99.
95. Tasaki K., Ruetzler C. A., Ohtsuki T., Martin D., Nawashiro H. Hallenbeck J. M. (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267 270.
96. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C. Simon J. C. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99 111.
97. Triantafilou M. Triantafilou K. (2004) Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem. Soc. Trans. 32, 636 639.
98. Tsan M. F. Gao B. (2004a) Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 286, C739 744.
99. Tsan M. F. Gao B. (2004b) Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514 519.
100. Veldhuis W. B., Derksen J. W., Floris S., et al. (2003) Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J. Cereb. Blood Flow Metab. 23, 1029 1039.
101. Wakselman S., Bechade C., Roumier A., Bernard D., Triller A. Bessis A. (2008) Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J. Neurosci. 28, 8138 8143.
102. Walter S., Letiembre M., Liu Y., et al. (2007) Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol. Biochem. 20, 947 956.
103. Wang A. C., Su Q. B., Wu F. X., Zhang X. L. Liu P. S. (2009) Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur. J. Clin. Invest. 39, 157 164.
104. Watkins L. R. Maier S. F. (1999) Implications of immune-to-brain communication for sickness and pain. Proc. Natl Acad. Sci. USA 96, 7710 7713.
105. Weatherill A. R., Lee J. Y., Zhao L., Lemay D. G., Youn H. S. Hwang D. H. (2005) Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174, 5390 5397.
106. Wong S. W., Kwon M. J., Choi A. M., Kim H. P., Nakahira K. Hwang D. (2009) Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a ros-dependent manner. J. Biol. Chem. 284, 27384 27392.
107. Wu H. E., Sun H. S., Cheng C. W., Terashvili M. Tseng L. F. (2006) dextro-Naloxone or levo-naloxone reverses the attenuation of morphine antinociception induced by lipopolysaccharide in the mouse spinal cord via a non-opioid mechanism. Eur. J. Neurosci. 24, 2575 2580.
108. Yamamoto M., Sato S., Hemmi H., et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640 643. (Pubitemid 36927946)
109. Yamada M., Ichikawa T., Ii M., Sunamoto M., Itoh K., Tamura N. Kitazaki T. (2005) Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate. J. Med. Chem. 48, 7457 7467.
110. Youn H. S., Lee J. Y., Fitzgerald K. A., Young H. A., Akira S. Hwang D. H. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 175, 3339 3346.
111. Youn H. S., Saitoh S. I., Miyake K. Hwang D. H. (2006) Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72, 62 69.
112. Youn H. S., Lee J. K., Choi Y. J., Saitoh S. I., Miyake K., Hwang D. H. Lee J. Y. (2008) Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem. Pharmacol. 75, 494 502.
113. Younger J. Mackey S. (2009) Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 10, 663 672.
114. Younger J. W., Zautra A. J. Cummins E. T. (2009) Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. PLoS One 4, e5180.
115. Yusuf N., Nasti T. H., Meleth S. Elmets C. A. (2009) Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Mol. Carcinog. 48, 713 723.
116. Zhao W., Beers D. R., Henkel J. S., Zhang W., Urushitani M., Julien J. P. Appel S. H. (2010) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231 243.
117. Zhou H., Lapointe B. M., Clark S. R., Zbytnuik L. Kubes P. (2006) A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J. Immunol. 177, 8103 8110.
118. Zimmer S. M., Liu J., Clayton J. L., Stephens D. S. Snyder J. P. (2008) Paclitaxel binding to human and murine MD-2. J. Biol. Chem. 283, 27916 27926.